Back to Awarded Treatment Trials
Awarded Trial: 03T-353
Grant ID
03T-353
Illness
Schizophrenia
Primary Drug/Intervention
17-beta Estradiol patch
Primary Dosage
100mcg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Wieck
Sample Size
24
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
PANSS, Calgary Depression Scale, GAF
Results
Premenopausal women with residual positive symptoms receiving a prolactin-elevating antipsychotic were eligible, and 13 patients completed the study. There was no significant effect of the drug compared to placebo.
Publication
N/A
Link
N/A
PI Name
Angelika Wieck
Degree
MD
Center
University of Manchester, Department of Psychiatry
Institution
N/A
Address
Laureate House, Wythenshawe Hospital, South Moor Road
City or Town
Manchester
State or Province
N/A
Zip or Postal Code
M23 9LT
Country
United Kingdom
Email Address
angelika.wieck@manchester.ac.uk